Vellas B

References (35)

Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178
Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS
Ref : Alzheimers Res Ther , 14 :178 , 2022
PubMedID: 36447240

Title : Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials - Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201
Author(s) : Yu JT , Xu W , Tan CC , Andrieu S , Suckling J , Evangelou E , Pan A , Zhang C , Jia J , Feng L , Kua EH , Wang YJ , Wang HF , Tan MS , Li JQ , Hou XH , Wan Y , Tan L , Mok V , Dong Q , Touchon J , Gauthier S , Aisen PS , Vellas B
Ref : Journal of Neurology Neurosurg Psychiatry , 91 :1201 , 2020
PubMedID: 32690803

Title : No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease - Chiam_2015_J.Alzheimers.Dis_47_741
Author(s) : Chiam JT , Lunnon K , Voyle N , Proitsi P , Coppola G , Geschwind D , Nelson S , Johnston C , Soininen H , Kloszewska I , Mecocci P , Tsolaki M , Vellas B , Hodges A , Lovestone S , Newhouse S , Dobson RJ , Kiddle SJ , Sattlecker M
Ref : J Alzheimers Dis , 47 :741 , 2015
PubMedID: 26401708

Title : A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe : Predictors of Discontinuation and Switch in the ICTUS Study - Gardette_2014_CNS.Drugs_28_157
Author(s) : Gardette V , Lapeyre-Mestre M , Piau A , Gallini A , Cantet C , Montastruc JL , Vellas B , Andrieu S
Ref : CNS Drugs , 28 :157 , 2014
PubMedID: 24408842

Title : Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR study - Rolland_2013_Alzheimers.Res.Ther_5_52
Author(s) : Rolland Y , Cantet C , Barreto PD , Cesari M , van Kan GA , Vellas B
Ref : Alzheimers Res Ther , 5 :52 , 2013
PubMedID: 24517197

Title : Psychotropic drug consumption at admission and discharge of nursing home residents - Rolland_2012_J.Am.Med.Dir.Assoc_13_407 e7
Author(s) : Rolland Y , Andrieu S , Crochard A , Goni S , Hein C , Vellas B
Ref : J Am Med Dir Assoc , 13 :407 e7 , 2012
PubMedID: 22264687

Title : Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease -
Author(s) : Vellas B
Ref : J Nutr Health Aging , 16 :330 , 2012
PubMedID: 22499451

Title : EHT0202 in Alzheimer's Disease: A 3-Month, Randomized, Placebo-Controlled, Double-Blind Study - Vellas_2011_Curr.Alzheimer.Res_8_203
Author(s) : Vellas B , Sol O , Snyder PJ , Ousset PJ , Haddad R , Maurin M , Lemarie JC , Desire L , Pando MP
Ref : Curr Alzheimer Res , 8 :203 , 2011
PubMedID: 21222604

Title : Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy - Delrieu_2011_CNS.Drugs_25_213
Author(s) : Delrieu J , Piau A , Caillaud C , Voisin T , Vellas B
Ref : CNS Drugs , 25 :213 , 2011
PubMedID: 21323393

Title : Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study - Gardette_2010_CNS.Drugs_24_431
Author(s) : Gardette V , Andrieu S , Lapeyre-Mestre M , Coley N , Cantet C , Ousset PJ , Grand A , Monstastruc JL , Vellas B
Ref : CNS Drugs , 24 :431 , 2010
PubMedID: 20369907

Title : Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease - Sanz_2009_Neurology_73_1359
Author(s) : Sanz C , Andrieu S , Sinclair A , Hanaire H , Vellas B
Ref : Neurology , 73 :1359 , 2009
PubMedID: 19858457

Title : Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease -
Author(s) : Touchon J , Vellas B , Katchaturian Z
Ref : J Nutr Health Aging , 13 :204 , 2009
PubMedID: 19262952

Title : Diagnosis and treatment of patients with severe Alzheimer's disease - Voisin_2009_Drugs.Aging_26_135
Author(s) : Voisin T , Vellas B
Ref : Drugs & Aging , 26 :135 , 2009
PubMedID: 19220070

Title : Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-up - Guerin_2009_Clin.Nutr_28_141
Author(s) : Guerin O , Andrieu S , Schneider SM , Cortes F , Cantet C , Gillette-Guyonnet S , Vellas B
Ref : Clin Nutr , 28 :141 , 2009
PubMedID: 19232792

Title : Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II - Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
Author(s) : Aalten P , Verhey FR , Boziki M , Brugnolo A , Bullock R , Byrne EJ , Camus V , Caputo M , Collins D , De Deyn PP , Elina K , Frisoni G , Holmes C , Hurt C , Marriott A , Mecocci P , Nobili F , Ousset PJ , Reynish E , Salmon E , Tsolaki M , Vellas B , Robert PH
Ref : Dementia & Geriatric Cognitive Disorders , 25 :1 , 2008
PubMedID: 18025783

Title : Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study - Coley_2008_Neuroepidemiology_31_69
Author(s) : Coley N , Gardette V , Toulza O , Gillette-Guyonnet S , Cantet C , Nourhashemi F , Andrieu S , Grand A , Vellas B
Ref : Neuroepidemiology , 31 :69 , 2008
PubMedID: 18622142

Title : Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? - Vellas_2007_J.Nutr.Health.Aging_11_338
Author(s) : Vellas B , Andrieu S , Cantet C , Dartigues JF , Gauthier S
Ref : J Nutr Health Aging , 11 :338 , 2007
PubMedID: 17653494

Title : Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes -
Author(s) : Gillette-Guyonnet S , Andrieu S , Nourhashemi F , Reynish E , Vellas B
Ref : J Gerontol A Biol Sci Med Sci , 62 :679 , 2007
PubMedID: 17595427

Title : Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials? - Cortes_2007_J.Nutr.Health.Aging_11_330
Author(s) : Cortes F , Portet F , Touchon J , Vellas B
Ref : J Nutr Health Aging , 11 :330 , 2007
PubMedID: 17653493

Title : Editorial: outcomes for Alzheimer's trials - Vellas_2007_J.Nutr.Health.Aging_11_313
Author(s) : Vellas B
Ref : J Nutr Health Aging , 11 :313 , 2007
PubMedID:

Title : Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors - Gillette-Guyonnet_2006_J.Gerontol.A.Biol.Sci.Med.Sci_61_516
Author(s) : Gillette-Guyonnet S , Andrieu S , Cortes F , Nourhashemi F , Cantet C , Ousset PJ , Reynish E , Grandjean H , Vellas B
Ref : J Gerontol A Biol Sci Med Sci , 61 :516 , 2006
PubMedID: 16720751

Title : [Treatment of Alzheimer's disease] - Bombois_2005_Rev.Prat_55_1913
Author(s) : Bombois S , Lebert F , Vellas B , Pasquier F
Ref : Rev Prat , 55 :1913 , 2005
PubMedID: 16396232

Title : Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort - Gillette-Guyonnet_2005_J.Nutr.Health.Aging_9_69
Author(s) : Gillette-Guyonnet S , Cortes F , Cantet C , Vellas B
Ref : J Nutr Health Aging , 9 :69 , 2005
PubMedID: 15791348

Title : Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease - Vellas_2005_Curr.Med.Res.Opin_21_1423
Author(s) : Vellas B , Cunha L , Gertz HJ , De Deyn PP , Wesnes K , Hammond G , Schwalen S
Ref : Curr Med Res Opin , 21 :1423 , 2005
PubMedID: 16197661

Title : The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia - Rikkert_2005_Eur.J.Neurol_12_212
Author(s) : Rikkert MG , Lauque S , Frolich L , Vellas B , Dekkers W
Ref : Eur Journal of Neurology , 12 :212 , 2005
PubMedID: 15693811

Title : Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study - Cortes_2005_J.Nutr.Health.Aging_9_86
Author(s) : Cortes F , Gillette-Guyonnet S , Nourhashemi F , Andrieu S , Cantet C , Vellas B
Ref : J Nutr Health Aging , 9 :86 , 2005
PubMedID: 15791351

Title : Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial - Feldman_2005_Int.J.Geriatr.Psychiatry_20_559
Author(s) : Feldman H , Gauthier S , Hecker J , Vellas B , Xu Y , Ieni JR , Schwam EM
Ref : Int J Geriatr Psychiatry , 20 :559 , 2005
PubMedID: 15920715

Title : Impact of Nutritional Status on the Evolution of Alzheimer's Disease and on Response to Acetylcholinesterase Inhibitor Treatment - Vellas_2005_J.Nutr.Health.Aging_9_75
Author(s) : Vellas B , Lauque S , Gillette-Guyonnet S , Andrieu S , Cortes F , Nourhashemi F , Cantet C , Ousset PJ , Grandjean H
Ref : J Nutr Health Aging , 9 :75 , 2005
PubMedID: 15791349

Title : Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients - Guerin_2005_Am.J.Clin.Nutr_82_435
Author(s) : Guerin O , Andrieu S , Schneider SM , Milano M , Boulahssass R , Brocker P , Vellas B
Ref : Am J Clin Nutr , 82 :435 , 2005
PubMedID: 16087990

Title : What are the treatment options for patients with severe Alzheimer's disease? - Voisin_2004_CNS.Drugs_18_575
Author(s) : Voisin T , Reynish E , Portet F , Feldman H , Vellas B
Ref : CNS Drugs , 18 :575 , 2004
PubMedID: 15222774

Title : No additional benefit of HRT on response to rivastigmine in menopausal women with AD -
Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ
Ref : Neurology , 60 :148 , 2003
PubMedID: 12525745

Title : [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study] - Rigaud_2003_Presse.Med_32_1649
Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ , Loria-Kanza Y
Ref : Presse Med , 32 :1649 , 2003
PubMedID: 14631268

Title : The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results - Gillette-Guyonnet_2003_J.Nutr.Health.Aging_7_91
Author(s) : Gillette-Guyonnet S , Nourhashemi F , Andrieu S , Cantet C , Micas M , Ousset PJ , Vellas B
Ref : J Nutr Health Aging , 7 :91 , 2003
PubMedID: 12679828

Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil - Auriacombe_2002_Curr.Med.Res.Opin_18_129
Author(s) : Auriacombe S , Pere JJ , Loria-Kanza Y , Vellas B
Ref : Curr Med Res Opin , 18 :129 , 2002
PubMedID: 12094822

Title : Abnormal movements with donepezil in Alzheimer disease -
Author(s) : Amouyal-Barkate K , Bagheri-Charabiani H , Montastruc JL , Moulias S , Vellas B
Ref : Annals of Pharmacotherapy , 34 :1347 , 2000
PubMedID: 11098352